As promised earlier, China Medical Technologies (中国医疗技术公司) released selected Q2 (ended September 30, 2008) results, though a full disclosure, complete with analysts’ call, will wait until December 18. The problem with a full release is reporting issues: China Medical is deciding how to account for its very large $345 million purchase of the HPV-DNA Chip and SPR-based Analysis System. In the meantime, China Medical has the good fortune of being able to report very positive results for its ongoing business. More details...

Stock Symbol: (NSDQ: CMED)